Back to top

Bernstein Remains a Buy on Abbott Laboratories (ABT)

Bernstein analyst Lee Hambright maintained a Buy rating on Abbott Laboratories on September 8 and set a price target of $145.00. The company’s shar...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Abacus Life, Inc. (ABL)

Abbott Laboratories (ABT)